🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

6 Liquid Softgel(s) Serving Size
30 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

4170 mg
📊 Market median: 200.0mg (52 products) 📚 10 studies (Tier A: 0, B: 6)
This product: 4170mg
HemodrauliX Proprietary Blend
3000 mg

Other Ingredients

Kosher Gelatin Glycerin Beeswax purified Water Lecithin Titanium Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (83% of products) Nutrient (6% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 6 SoftGels 30 minutes prior to exercise. For best results, do not take more than once a day or more than 5 times a week. Supplement daily with a multivitamin while using Hemodraulix(TM).

⚠️ Warnings & Precautions

This product is not intended for anyone under the age of 18, pregnant or nursing. Consult your physician before using this or any dietary supplement. Do not take this product if you have any medical condition and/or are taking any prescription medication(s). Do not use if you have, or are at risk of, a myocardial infarction (heart attack), diabetes, asthma, high blood pressure, high cholesterol, arthritis, cancer, stroke, or suffering from any inflammatory diseases, or are on a red meat restricted diet. Discontinue use if experiencing any adverse side effects.

WARNING: KEEP OUT OF REACH OF CHILDREN.

Additional Information

Store in a cool place. Protect from heat, light and moisture.

Anabolic Hyper-Vasodilation System With Arachidonic Acid and NE2(R) • Up-Regulates N.O. Production* • Unmatched Skin Bursting Pumps* • Deep Muscle Fiber Stimulation* • Improved Protein Synthesis* • Ignites Lipolysis (Fat into Muscles)* • Increases Bedroom Performance*

LOT

Manufactured at a FDA Inspected Facility

Manufactured with pride in the USA.

Potency and Purity GUARANTEED

int: 303-221-2110

Product Details

UPC / SKU 6 89076 41246 9
DSLD Entry Date 2011-10-26
Product Type Other Combinations
Form Softgel Capsule
Brand Axis Labs
DSLD ID 1064
Data Updated 2026-04-11

Research Evidence

12 Research Sources
58 Avg Quality Score
8 Meta Analysis
3 Systematic Review
1 Rct
B S-adenosyl-L-methionine for alcoholic liver diseases
Meta Analysis The Cochrane database of systematic reviews 2006
B S-adenosyl methionine (SAMe) for depression in adults
Meta Analysis The Cochrane database of systematic reviews 2016
B Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
Meta Analysis Annals of the rheumatic diseases 2024
B SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis
Meta Analysis American journal of cardiovascular drugs : drugs, devices, and other interventions 2024
B S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024
B S-adenosyl-L-methionine for alcoholic liver diseases
Systematic Review The Cochrane database of systematic reviews 2001
B WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases
Meta Analysis The Cochrane database of systematic reviews 2015
C S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis
Meta Analysis PloS one 2015
C S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review
Systematic Review Nutrients 2024
C SAMe-TT2R2 to Predict Clinical Outcomes and Time in Therapeutic Range in Patients on Vitamin K Antagonists: A Systematic Review and Meta-Analysis
Meta Analysis The Annals of pharmacotherapy 2024
View all evidence for Same →

Compare Similar Products

View all Same products →